Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Broderick

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
The Annals of Thoracic Surgery|February 19, 2014
National cooperative group trials of "high-risk" patients with lung cancer: are they truly "high-risk"?Varun Puri, Traves D Crabtree, Jennifer M Bell, et al.
The Journal of Surgical Research|August 17, 2024
Maryland's Global Budget Revenue Program and Equitable Access to Esophagectomy for Esophageal CancerVictor B Yang, Hannah J Rando, Arjun K Menta, et al.
The Annals of Thoracic Surgery|April 20, 2015
Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung CancerPamela Samson, Aalok Patel, Tasha Garrett, et al.
The Annals of Thoracic Surgery|April 17, 2016
Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction TherapyPamela Samson, Varun Puri, Clifford Robinson, et al.
The Annals of Thoracic Surgery|January 24, 2017
Defining the Ideal Time Interval Between Planned Induction Therapy and Surgery for Stage IIIA Non-Small Cell Lung CancerPamela Samson, Traves D Crabtree, Cliff G Robinson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 22, 2016
Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer PatientsPamela Samson, Clifford Robinson, Jeffrey Bradley, et al.
The Annals of Thoracic Surgery|April 23, 2014
Comparison of pyloric intervention strategies at the time of esophagectomy: is more better?Mara B Antonoff, Varun Puri, Bryan F Meyers, et al.
The Journal of Surgical Research|May 16, 2024
Rectus Abdominis Muscle Atrophy and Asymmetry After Pulmonary LobectomyAidan S Weitzner, Myan Bhoopalam, Jeffrey Khong, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 28, 2015
The National Surgical Quality Improvement Program risk calculator does not adequately stratify risk for patients with clinical stage I non-small cell lung cancerPamela Samson, Clifford G Robinson, Jeffrey Bradley, et al.
Practical Radiation Oncology|July 2, 2018
Preoperative contralateral lung radiation dose is associated with postoperative pulmonary toxicity in patients with locally advanced non-small cell lung cancer treated with trimodality therapyWenji Guo, Xuan Hui, Salem Alfaifi, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
The Annals of Thoracic Surgery|February 19, 2014
National cooperative group trials of "high-risk" patients with lung cancer: are they truly "high-risk"?Varun Puri, Traves D Crabtree, Jennifer M Bell, et al.
The Journal of Surgical Research|August 17, 2024
Maryland's Global Budget Revenue Program and Equitable Access to Esophagectomy for Esophageal CancerVictor B Yang, Hannah J Rando, Arjun K Menta, et al.
The Annals of Thoracic Surgery|April 20, 2015
Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung CancerPamela Samson, Aalok Patel, Tasha Garrett, et al.
The Annals of Thoracic Surgery|April 17, 2016
Clinical T2N0 Esophageal Cancer: Identifying Pretreatment Characteristics Associated With Pathologic Upstaging and the Potential Role for Induction TherapyPamela Samson, Varun Puri, Clifford Robinson, et al.
The Annals of Thoracic Surgery|January 24, 2017
Defining the Ideal Time Interval Between Planned Induction Therapy and Surgery for Stage IIIA Non-Small Cell Lung CancerPamela Samson, Traves D Crabtree, Cliff G Robinson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 22, 2016
Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer PatientsPamela Samson, Clifford Robinson, Jeffrey Bradley, et al.
The Annals of Thoracic Surgery|April 23, 2014
Comparison of pyloric intervention strategies at the time of esophagectomy: is more better?Mara B Antonoff, Varun Puri, Bryan F Meyers, et al.
The Journal of Surgical Research|May 16, 2024
Rectus Abdominis Muscle Atrophy and Asymmetry After Pulmonary LobectomyAidan S Weitzner, Myan Bhoopalam, Jeffrey Khong, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 28, 2015
The National Surgical Quality Improvement Program risk calculator does not adequately stratify risk for patients with clinical stage I non-small cell lung cancerPamela Samson, Clifford G Robinson, Jeffrey Bradley, et al.
Practical Radiation Oncology|July 2, 2018
Preoperative contralateral lung radiation dose is associated with postoperative pulmonary toxicity in patients with locally advanced non-small cell lung cancer treated with trimodality therapyWenji Guo, Xuan Hui, Salem Alfaifi, et al.
Pageof 5